Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | ANPEP | P15144 | 1/20 | 0.38 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.36 |
| ▸ | RAD52 | P43351 | 1/20 | 0.36 |
| ▸ | PADI1 | Q9ULC6 | 1/20 | 0.35 |
| ▸ | PADI4 | Q9UM07 | 1/20 | 0.35 |
| ▸ | PHGDH | O43175 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22320733 | 1.00 | SMN1; SMN2 (0.46) | SMN1; SMN2CHRM5CHRM3POLBHSD17B10 | |
| SCHEMBL8460966 | 0.90 | CXCR4 (0.47) | SMN1; SMN2CHRM5CHRM3POLBHSD17B10 | |
| SCHEMBL104625 | 0.84 | SMN1; SMN2 (0.45) | SMN1; SMN2CHRM5CHRM3POLBHSD17B10 | |
| SCHEMBL1408746 | 0.84 | SMN1; SMN2 (0.45) | SMN1; SMN2CHRM5CHRM3POLBHSD17B10 | |
| SCHEMBL9319178 | 0.83 | HRH3 (0.38) | SMN1; SMN2KMT2A | |
| Hydrochloric Acid SCHEMBL25326103 | 0.82 | SMN1; SMN2 (0.43) | SMN1; SMN2CHRM5CHRM3POLBHSD17B10 | |
| SCHEMBL9329894 | 0.82 | SMN1; SMN2 (0.43) | SMN1; SMN2CHRM5CHRM3POLBHSD17B10 | |
| SCHEMBL6424566 | 0.81 | SMN1; SMN2 (0.42) | SMN1; SMN2CHRM5CHRM3POLBHSD17B10 | |
| SCHEMBL8370583 | 0.80 | ANPEP (0.44) | SMN1; SMN2CHRM5CHRM3POLBHSD17B10 | |
| SCHEMBL22710095 | 0.80 | SMN1; SMN2 (0.42) | SMN1; SMN2CHRM5CHRM3POLBHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102639686-A | Cleaning fluid composition and a cleaning method for a panel using the same | DONGWOO FINE CHEM CO LTD | 2012-08-15 | — | — | CN | claimed |
| US-11773078-B2 | Furin inhibitors | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2023-10-03 | — | — | US | disclosed |
| US-20220315556-A1 | FURIN INHIBITORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2022-10-06 | — | — | US | disclosed |
| CN-112739343-A | Macrocyclic MCL-1 inhibitors and methods of use | 艾伯维公司 | 2021-04-30 | — | — | CN | disclosed |
| US-20200255451-A1 | MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE | ABBVIE INC (US) | 2020-08-13 | — | — | US | disclosed |
| CN-109053989-B | Preparation method of tear-resistant waterborne polyurethane emulsion for medical waterborne polyurethane film | 兰州科天健康科技股份有限公司 | 2019-12-10 | — | — | CN | disclosed |
| CN-102639686-A | Cleaning fluid composition and a cleaning method for a panel using the same | DONGWOO FINE CHEM CO LTD | 2012-08-15 | — | — | CN | disclosed |
| US-4992150-A | Telomer with alpha-olefin;oil and fuel additive | NIPPON OIL CO, LTD. (JP) | 1991-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220315556-A1 | FURIN INHIBITORS | FURIN, TGFB1, PCSK7 | SMN1; SMN2 2206/4885CHRM5 4355/4885CHRM3 3969/4885 |
| US-20200255451-A1 | MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE | MCL1, BCL2A1, BCL2L10 | SMN1; SMN2 609/4885CHRM5 3305/4885CHRM3 4590/4885 |
| US-11773078-B2 | Furin inhibitors | FURIN, TGFB1, PCSK7 | SMN1; SMN2 2206/4885CHRM5 4355/4885CHRM3 3969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.